PAIELLA, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 4.394
EU - Europa 4.313
AS - Asia 1.636
SA - Sud America 23
OC - Oceania 13
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.391
Nazione #
US - Stati Uniti d'America 4.369
CN - Cina 1.228
GB - Regno Unito 1.147
IT - Italia 739
SE - Svezia 499
IE - Irlanda 485
FR - Francia 408
DE - Germania 349
RU - Federazione Russa 329
SG - Singapore 181
FI - Finlandia 149
UA - Ucraina 58
HK - Hong Kong 50
JP - Giappone 43
CZ - Repubblica Ceca 34
KR - Corea 33
NL - Olanda 24
TR - Turchia 24
BE - Belgio 23
VN - Vietnam 20
IN - India 19
CA - Canada 18
BR - Brasile 12
AU - Australia 11
IR - Iran 11
CH - Svizzera 8
AT - Austria 7
DK - Danimarca 7
PL - Polonia 6
ES - Italia 5
GR - Grecia 5
LV - Lettonia 5
AL - Albania 4
CL - Cile 4
SK - Slovacchia (Repubblica Slovacca) 4
EG - Egitto 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
MX - Messico 3
NO - Norvegia 3
PA - Panama 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
GH - Ghana 2
HU - Ungheria 2
IQ - Iraq 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
AR - Argentina 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
GI - Gibilterra 1
ID - Indonesia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 10.391
Città #
Southend 1.107
Chandler 1.085
Dublin 464
Ashburn 326
Beijing 264
Woodbridge 239
Jacksonville 226
Verona 188
Ann Arbor 169
Houston 169
New York 154
Lawrence 150
Princeton 150
Wilmington 132
Boardman 131
Singapore 119
Jinan 110
Helsinki 92
Nanjing 92
Shenyang 89
Sindelfingen 75
Seattle 67
Redmond 61
Hebei 55
Hong Kong 50
Fairfield 43
Haikou 42
Tianjin 42
Hangzhou 40
Milan 40
Ningbo 39
Bologna 36
Zhengzhou 36
Redwood City 34
Tokyo 33
Nanchang 32
Seoul 32
Washington 32
Changsha 31
Brno 30
Taiyuan 28
Taizhou 27
Falls Church 24
Los Angeles 24
Brussels 23
Jiaxing 21
Guangzhou 19
San Francisco 19
Norwalk 18
Chicago 17
Kent 16
Rome 16
Fuzhou 15
Dallas 14
Dongguan 14
Lancaster 14
Falkenstein 13
Dong Ket 12
Henderson 11
Lanzhou 11
Lappeenranta 11
Menlo Park 11
Toronto 10
Amsterdam 9
Düsseldorf 9
Genova 9
Munich 9
Trento 9
Clearwater 8
Malatya 8
Padova 8
Columbus 7
Crugers 7
Foersloev 7
Frankfurt am Main 7
London 7
Vienna 7
Cambridge 6
Dearborn 6
Foresto 6
Pignone 6
Renton 6
Sant'Ambrogio di Valpolicella 6
Atlanta 5
Bolzano 5
Buffalo 5
Cedar Knolls 5
Chions 5
Moscow 5
Osaka 5
Rimini 5
São Paulo 5
Tombolo 5
Berlin 4
Bratislava 4
Cagliari 4
Herndon 4
Iglesias 4
Landshut 4
Monza 4
Totale 6.919
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 347
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 149
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 116
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 115
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 112
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 111
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 110
Results of a surveillance protocol for pancreatic BD-IPMNs 109
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 107
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 105
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 104
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 102
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 101
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 100
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 100
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 98
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 98
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 98
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 96
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 95
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 90
A root-cause analysis of mortality following major pancreatectomy 89
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 89
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 88
Minimally invasive pancreatic surgery - a review 86
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 84
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 84
Delaying surgery for patients with a previous SARS-CoV-2 infection 84
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 83
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer 83
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 83
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 83
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 83
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 83
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 82
Fhit down-regulation is an early event in pancreatic carcinogenesis 81
Surveillance for Pancreatic Cancer in High-Risk Individuals: First-Round Screening Results of a Multicentric Italian Program 81
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 78
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 78
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 78
Gα15 in early onset of pancreatic ductal adenocarcinoma 78
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 76
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 76
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 76
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 76
Surgery for Distal Cholangiocarcinoma 74
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 72
Percutaneous ablation of pancreatic cancer 71
Detection and Treatment of Pancreatic Cancer and High-Grade Precursor Lesions in High-Risk Individuals Undergoing Surveillance: Results From the International CAPS Consortium Registry 71
Postoperative infectious complications as potential negative predictors: Analysis of 600 consecutive pancreaticoduodenectomies 71
Erratum: The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging 71
Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer 69
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 69
Perioperative management of patients undergoing pancreatic resection: implementation of a care plan in a tertiary-care center. 68
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 68
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 68
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 67
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 67
Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study 65
Very high serum levels of CA 19-9 in autoimmune pancreatitis: Report of four cases and brief review of literature 65
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 65
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 65
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 65
Tumour thrombosis: an uncommon finding associated with pancreatic tumours 64
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 64
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. 63
Selective agenesis of pancreatic isthmus parenchyma with preservation of main pancreatic duct continuity, a very rare entity: Case report 62
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 62
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 62
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 62
US-Guided Percutaneous Radiofrequency Ablation of Locally Advanced Pancreatic Adenocarcinoma: A 5-Year High-Volume Center Experience 62
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 61
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 61
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 61
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 61
Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality 60
Radiofrequency Ablation of Pancreatic Cancer 60
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 60
Prevention and management of complications after ablative therapies on the pancreas 59
Preoperative fine-needle aspiration of pancreatic neuroendocrine tumors: a reliable tool to assess diagnosis and grading - A prospective single-center analysis of 100 cases 59
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 59
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 59
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 59
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting 58
ESGAR 2018 Book of Abstracts 57
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 57
Ablation treatments in unresectable pancreatic cancer 57
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 57
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 56
The management of intraductal papillary mucinous neoplasms of the pancreas 55
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 55
Sex differences in oncogenic mutational processes 54
Seasonal variations in pancreatic surgery outcome A retrospective time-trend analysis of 2748 Whipple procedures 54
Le terapie ablative delle neoplasie pancreatiche 54
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 54
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 54
Pancreatic surgery is a safe teaching model for tutoring residents in the setting of a high-volume academic hospital: a retrospective analysis of surgical and pathological outcomes 53
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 53
Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector Analysis 52
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 52
Totale 7.808
Categoria #
all - tutte 42.366
article - articoli 39.771
book - libri 0
conference - conferenze 911
curatela - curatele 0
other - altro 148
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.536
Totale 84.732


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020677 0 16 18 38 90 81 97 22 50 50 77 138
2020/20211.237 140 181 56 245 139 121 48 36 60 41 94 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/2025423 283 140 0 0 0 0 0 0 0 0 0 0
Totale 10.675